Integral Ad Science Holding Corp. (NASDAQ:IAS) Shares Sold by Boothbay Fund Management LLC

Boothbay Fund Management LLC reduced its stake in Integral Ad Science Holding Corp. (NASDAQ:IAS - Free Report) by 33.0% during the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 117,707 shares of the company's stock after selling 58,027 shares during the period. Boothbay Fund Management LLC owned approximately 0.07% of Integral Ad Science worth $1,229,000 at the end of the most recent quarter.

Other large investors also recently bought and sold shares of the company. Price T Rowe Associates Inc. MD grew its stake in shares of Integral Ad Science by 17.2% in the fourth quarter. Price T Rowe Associates Inc. MD now owns 27,997 shares of the company's stock valued at $293,000 after buying an additional 4,099 shares in the last quarter. ClearAlpha Technologies LP acquired a new position in Integral Ad Science in the 4th quarter valued at about $143,000. MetLife Investment Management LLC increased its stake in Integral Ad Science by 10.1% during the fourth quarter. MetLife Investment Management LLC now owns 44,921 shares of the company's stock worth $469,000 after purchasing an additional 4,123 shares during the period. Dimensional Fund Advisors LP lifted its position in shares of Integral Ad Science by 18.1% during the fourth quarter. Dimensional Fund Advisors LP now owns 3,789,996 shares of the company's stock worth $39,567,000 after purchasing an additional 580,323 shares in the last quarter. Finally, First Trust Advisors LP boosted its stake in shares of Integral Ad Science by 295.6% in the fourth quarter. First Trust Advisors LP now owns 171,378 shares of the company's stock valued at $1,789,000 after purchasing an additional 128,056 shares during the period. Institutional investors and hedge funds own 95.78% of the company's stock.

Integral Ad Science Stock Up 0.6 %

Shares of NASDAQ:IAS traded up $0.04 during trading on Thursday, hitting $7.11. 677,418 shares of the company were exchanged, compared to its average volume of 1,088,330. The company has a debt-to-equity ratio of 0.07, a current ratio of 3.71 and a quick ratio of 3.71. The firm's 50 day moving average price is $8.19 and its 200-day moving average price is $9.88. The stock has a market capitalization of $1.16 billion, a P/E ratio of 35.55, a PEG ratio of 1.06 and a beta of 1.53. Integral Ad Science Holding Corp. has a 12-month low of $6.26 and a 12-month high of $13.62.

Integral Ad Science (NASDAQ:IAS - Get Free Report) last announced its quarterly earnings results on Friday, February 28th. The company reported $0.09 earnings per share for the quarter, missing analysts' consensus estimates of $0.12 by ($0.03). Integral Ad Science had a net margin of 6.39% and a return on equity of 3.47%. The company had revenue of $153.00 million during the quarter, compared to analysts' expectations of $148.83 million. During the same period last year, the firm earned $0.06 earnings per share. Integral Ad Science's revenue was up 13.9% on a year-over-year basis. On average, research analysts predict that Integral Ad Science Holding Corp. will post 0.26 earnings per share for the current fiscal year.

Insider Buying and Selling

In other Integral Ad Science news, CEO Lisa Utzschneider sold 8,547 shares of Integral Ad Science stock in a transaction on Monday, April 7th. The shares were sold at an average price of $6.85, for a total value of $58,546.95. Following the transaction, the chief executive officer now directly owns 341,271 shares in the company, valued at approximately $2,337,706.35. The trade was a 2.44 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Insiders have sold 90,303 shares of company stock worth $706,660 in the last quarter. 2.00% of the stock is owned by insiders.

Analyst Ratings Changes

A number of equities research analysts have issued reports on IAS shares. Morgan Stanley reduced their target price on shares of Integral Ad Science from $13.50 to $12.50 and set an "equal weight" rating on the stock in a report on Thursday, April 17th. Barclays reduced their price objective on Integral Ad Science from $14.00 to $7.00 and set an "equal weight" rating on the stock in a research note on Monday, April 21st. Stifel Nicolaus lowered their target price on Integral Ad Science from $15.00 to $13.00 and set a "buy" rating for the company in a research note on Wednesday, April 23rd. Scotiabank initiated coverage on Integral Ad Science in a research report on Friday, February 28th. They issued a "sector perform" rating and a $12.00 price target on the stock. Finally, Robert W. Baird reissued a "neutral" rating and set a $9.00 price objective (down from $16.00) on shares of Integral Ad Science in a research report on Friday, March 28th. Six investment analysts have rated the stock with a hold rating and six have given a buy rating to the company's stock. Based on data from MarketBeat, the stock currently has a consensus rating of "Moderate Buy" and a consensus target price of $13.55.

Integral Ad Science Profile

Integral Ad Science Holding Corp. operates as a digital advertising verification company in the United States, the United Kingdom, France, Ireland, Germany, Italy, Singapore, Australia, Japan, India, and the Nordics. The company provides IAS Signal, a cloud-based technology platform that offers return on ad spend needs; and deliver independent measurement and verification of digital advertising across devices, channels, and formats, including desktop, mobile, connected TV, social, display, and video.